Status:

COMPLETED

Project Orleu: Reducing Intersectional and HIV Stigma Among Health Care Providers and High Risk Women Who Use Drugs in Kazakhstan

Lead Sponsor:

Columbia University

Collaborating Sponsors:

Fogarty International Center of the National Institute of Health

University of Pennsylvania

Conditions:

Stigma, Social

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Suboptimal linkage to and retention in HIV prevention and care is prevalent among high-risk women who use or inject drugs in both the US and globally, including high HIV incidence contexts like Kazakh...

Detailed Description

Suboptimal linkage to and retention in HIV prevention and care is prevalent among high-risk women who use or inject drugs in both the US and globally, stemming, in part, from high levels of stigma. In...

Eligibility Criteria

Inclusion

  • Providers (e.g., physicians, nurses, clinic directors, epidemiologists, outreach workers)
  • Aged 18 years or older
  • Currently employed part or full-time at an AIDS Center friendly clinic (city clinics focused on the provision of HIV and sexual health care).

Exclusion

  • \- Providers who are less than 18 years of age and/or do not work at an AIDS center friendly clinic.

Key Trial Info

Start Date :

August 15 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 15 2025

Estimated Enrollment :

83 Patients enrolled

Trial Details

Trial ID

NCT06932796

Start Date

August 15 2024

End Date

May 15 2025

Last Update

July 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Global Health Research Center for Central Asia

Almaty, Kazakhstan